上海现代制药

Shanghai Shyndec Pharmaceutical Co., Ltd. is a prominent Chinese pharmaceutical company and the core industrial platform for chemical drugs within the Sinopharm (China National Pharmaceutical Group) ecosystem. Established in 1998 and headquartered in Shanghai, the company specializes in the research, development, and large-scale manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms. Its extensive product portfolio covers critical therapeutic areas such as anti-infectives, cardiovascular health, endocrinology, and oncology. Shyndec operates multiple high-standard manufacturing bases across China, ensuring a robust supply chain for both domestic and international markets. The company is publicly listed on the Shanghai Stock Exchange and continues to drive growth through the integration of Sinopharm's industrial assets and a focus on high-quality generic medications.